The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...
Rates are expected to drop in 2025, but a CD ladder can help you earn higher APYs on multiple CDs into the future while maintaining flexibility with your money.